Kristine Peterson Immuno Gen, Inc. (IMGN) insider trading activity

Kristine Peterson is Director of ImmunoGen, Inc.. Currently has a direct ownership of 0 shares of IMGN, which is worth approximately $0. The most recent transaction as insider was on Nov 30, 2023, when has been sold 20,000 shares (Common Stock) at a price of $28.9 per share, resulting in proceeds of $578,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

0% 3M change

0% 12M change

Total Value Held $0

Kristine Peterson Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Nov 30 2023	SELL Open market or private sale	$578,000 $28.9 p/Share	20,000 Reduced 100.0%	0 Common Stock
Nov 30 2023	BUY Exercise of conversion of derivative security	$231,800 $11.59 p/Share	20,000 Added 50.0%	20,000 Common Stock
Sep 13 2023	SELL Exercise of conversion of derivative security	$160,799 $16.08 p/Share	10,000 Reduced 100.0%	0 Common Stock
Sep 13 2023	BUY Exercise of conversion of derivative security	$147,000 $14.7 p/Share	10,000 Added 50.0%	10,000 Common Stock

Also insider at

PRTK

Paratek Pharmaceuticals, Inc. Healthcare

Director

ENTA

ENANTA PHARMACEUTICALS INC Healthcare

Director

AMRN

AMARIN CORP PLCUK Healthcare

AVBP

ArriVent Biopharma, Inc.

Director

IMCR

Immunocore Holdings plc Healthcare